Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 56051-56100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04857775
Adaptation and Pilot Testing of Web and Mobile Interface for the ATTACH™ Intervention
NARecruiting
100 participants
Started: Mar 15, 2021 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT04675593
Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders
NARecruiting
175 participants
Started: Mar 15, 2021 · Completed: Jun 1, 2026
4 conditions3 sponsors1 location
NCT06663111
Rituximab and Ocrelizumab in Serum With Multiple Sclerosis
N/ARecruiting
60 participants
Started: Mar 15, 2021 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT04811794
Young Survivors at Kantonsspital Aarau, Switzerland
N/ARecruiting
300 participants
Started: Mar 15, 2021 · Completed: Mar 15, 2072
2 conditions1 sponsor1 location
NCT04421326
Multimodal Investigation of Intracranial Clot Environment
N/ARecruiting
200 participants
Started: Mar 14, 2021 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT04802603
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
NARecruiting
60 participants
Started: Mar 14, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04820166
The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH
N/ARecruiting
200 participants
Started: Mar 12, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04684459
Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors
EARLY_PHASE1Recruiting
18 participants
Started: Mar 12, 2021 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT04787029
Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study
NARecruiting
150 participants
Started: Mar 12, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04772001
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
NARecruiting
53 participants
Started: Mar 12, 2021 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT04946773
Deep Liver Phenotyping and Immunology Study
N/ARecruiting
100 participants
Started: Mar 12, 2021 · Completed: Oct 31, 2040
2 conditions1 sponsor1 location
NCT04263831
Low Dose IL-2 for the Treatment of Crohn's Disease
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 11, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT05676320
Investigating Bone Cement With or Without Inossia™ Cement Softener for Vertebral Compression Fractures
NARecruiting
150 participants
Started: Mar 11, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors7 locations
NCT04799002
Topotecan and Melphalan for Retinoblastoma
PHASE3Recruiting
50 participants
Started: Mar 11, 2021 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT04715646
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
PHASE3Recruiting
70 participants
Started: Mar 11, 2021 · Completed: Jul 8, 2030
1 condition1 sponsor36 locations
NCT05035693
Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
NARecruiting
170 participants
Started: Mar 11, 2021 · Completed: Mar 11, 2027
4 conditions1 sponsor7 locations
NCT04804683
European/International FMD Registry and Initiative
NARecruiting
5,000 participants
Started: Mar 11, 2021 · Completed: Mar 10, 2031
1 condition1 sponsor1 location
NCT04797143
Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment
N/ARecruiting
300 participants
Started: Mar 11, 2021 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT05750979
Quantifying Disease Progression in LBSL
N/ARecruiting
20 participants
Started: Mar 11, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05826548
Financial Abilities in Neurological Diseases. Development of a Telerehabilitation Program: FINAGE
NARecruiting
140 participants
Started: Mar 11, 2021 · Completed: Feb 17, 2025
3 conditions4 sponsors1 location
NCT04570761
"Effects of Auditory Brain Stimulation by Pink Noise on Memory Capacities in Alzheimer's Disease: Proof of Concept Study"
NARecruiting
30 participants
Started: Mar 11, 2021 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT04276701
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NARecruiting
500 participants
Started: Mar 10, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors6 locations
NCT04840004
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer
PHASE2Recruiting
24 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors4 locations
NCT04438213
Ertugliflozin in Chronic Heart Failure
PHASE2Recruiting
60 participants
Started: Mar 10, 2021 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04678167
Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
NARecruiting
51 participants
Started: Mar 10, 2021 · Completed: Mar 10, 2027
1 condition1 sponsor3 locations
NCT04713670
Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection
PHASE4Recruiting
1,200 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04779008
Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After CABG
NARecruiting
210 participants
Started: Mar 10, 2021 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT04278690
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
NARecruiting
425 participants
Started: Mar 10, 2021 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT04547166
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
PHASE2/PHASE3Recruiting
568 participants
Started: Mar 10, 2021 · Completed: Dec 30, 2026
1 condition1 sponsor5 locations
NCT04544592
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
PHASE1/PHASE2Recruiting
45 participants
Started: Mar 10, 2021 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT04515342
Sarcopenia, Fall and Osteoporosis in Chronic Kidney Disease
N/ARecruiting
140 participants
Started: Mar 10, 2021 · Completed: Jan 1, 2026
3 conditions2 sponsors2 locations
NCT04787939
Early Feeding After Oral Cavity Reconstruction
NARecruiting
89 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04557293
Effort-based Decision-making and CPAPadherence
NARecruiting
64 participants
Started: Mar 10, 2021 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT05971355
Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis
NARecruiting
200 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor5 locations
NCT04742478
ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)
N/ARecruiting
1,000 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT04774757
Systemic Therapy Sequenced Isolated PALND for mCRC
NARecruiting
39 participants
Started: Mar 10, 2021 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT04360681
Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
PHASE2Recruiting
120 participants
Started: Mar 9, 2021 · Completed: Dec 31, 2025
2 conditions6 sponsors2 locations
NCT04798820
The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)
NARecruiting
358 participants
Started: Mar 9, 2021 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT04751279
Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells
N/ARecruiting
80 participants
Started: Mar 9, 2021 · Completed: Jan 2, 2024
2 conditions1 sponsor1 location
NCT04686305
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
PHASE1Recruiting
244 participants
Started: Mar 9, 2021 · Completed: Jun 30, 2027
1 condition2 sponsors83 locations
NCT05918445
PM8002 in the Treatment of Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
380 participants
Started: Mar 9, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor48 locations
NCT06247267
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
N/ARecruiting
75 participants
Started: Mar 9, 2021 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05101265
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment
PHASE1Recruiting
24 participants
Started: Mar 9, 2021 · Completed: Jun 1, 2025
2 conditions1 sponsor6 locations
NCT04777994
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
PHASE1Recruiting
248 participants
Started: Mar 9, 2021 · Completed: Oct 31, 2026
1 condition2 sponsors30 locations
NCT04715685
Mind Body Balance for Pediatric Migraine
NARecruiting
260 participants
Started: Mar 9, 2021 · Completed: Aug 31, 2026
8 conditions2 sponsors2 locations
NCT04886635
Surgery As Needed for Oesophageal Cancer - 2
N/ARecruiting
360 participants
Started: Mar 9, 2021 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT05033691
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
NARecruiting
162 participants
Started: Mar 9, 2021 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT04486378
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
PHASE2Recruiting
327 participants
Started: Mar 8, 2021 · Completed: Aug 31, 2030
2 conditions2 sponsors121 locations
NCT04510597
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
PHASE3Recruiting
364 participants
Started: Mar 8, 2021 · Completed: Jul 31, 2033
3 conditions2 sponsors387 locations
NCT04013802
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
PHASE1Recruiting
47 participants
Started: Mar 8, 2021 · Completed: May 1, 2031
1 condition2 sponsors2 locations